Corbus Pharmaceuticals Holdings (CRBP) Share-based Compensation (2013 - 2025)

Corbus Pharmaceuticals Holdings has reported Share-based Compensation for 13 years, with the latest figure at $1.4 million in Q4 2025.

• On a quarterly basis, Share-based Compensation fell 15.07% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 67.26% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 77.44% from the prior year.
• Share-based Compensation was $1.4 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $1.4 million in the prior quarter.
• The five-year high for Share-based Compensation was $19.3 million in Q2 2022, with the low at $737979.0 in Q2 2024.
• Average Share-based Compensation over 5 years is $6.4 million, with a median of $1.5 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2025: Share-based Compensation sank 95.73% in 2023, then soared 111.79% in 2025.
• Over 5 years, Share-based Compensation stood at $1.8 million in 2021, then declined by 29.23% to $1.3 million in 2022, then sank by 37.05% to $799000.0 in 2023, then surged by 104.26% to $1.6 million in 2024, then declined by 15.07% to $1.4 million in 2025.
• The last three Share-based Compensation figures came in at $1.4 million (Q4 2025), $1.4 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.